Inventor · disambiguated record
Rami Lissilaa
Also filed as: LISSILAA RAMI
8 granted patents·8 pending applications·64 citations·filing 2012–2025
83Inventor score
Top patents by PatentIndex Score
16 records- 0192US9290576B2Antibodies that bind to TL1A and their usesGLENMARK PHARMACEUTICALS SA·Filed 2014·Granted Mar 22, 2016·22 cites·51 claims
- 0292US8748585B2Antibodies that bind to OX40 and their usesATTINGER ANTOINE·Filed 2012·Granted Jun 10, 2014·36 cites·68 claims
- 0389US11773166B2CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their productionIchnos Sciences SA·Filed 2018·Granted Oct 3, 2023·5 cites·12 claims
- 0482US11407839B2Antibodies that bind to OX40 and their usesIchnos Sciences SA·Filed 2019·Granted Aug 9, 2022·1 cites·30 claims
- 0581US12281169B2Antibodies that bind to OX40 and their usesIchnos Sciences SA·Filed 2022·Granted Apr 22, 2025·0 cites·28 claims
- 0677US2025250351A1Antibodies that bind to ox40 and their usesIchnos Sciences SA·Filed 2025·Application pending·0 cites
- 0772US12006367B2CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their productionIchnos Sciences SA·Filed 2022·Granted Jun 11, 2024·0 cites·9 claims
- 0865US2025215102A1Cd28/ox40 bispecific antibodiesSANOFI SA·Filed 2024·Application pending·0 cites
- 0964US12195546B2CD28/OX40 bispecific antibodiesSANOFI SA·Filed 2023·Granted Jan 14, 2025·0 cites·26 claims
- 1062US2014294824A1Antibodies that bind to ox40 and their usesGLENMARK PHARMACEUTICALS SA·Filed 2014·Application pending·0 cites
- 1158US2017260280A1Antibodies that Bind to OX40 and Their UsesGLENMARK PHARMACEUTICALS SA·Filed 2016·Application pending·0 cites
- 1257US2020079863A1Antibodies that bind to tl1a and their usesGLENMARK PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 1351US2018086840A1Antibodies that bind to tl1a and their usesGLENMARK PHARMACEUTICALS SA·Filed 2017·Application pending·0 cites
- 1441US2020347143A1Novel tnfr agonists and uses thereofIchnos Sciences SA·Filed 2017·Application pending·0 cites
- 1538US10640564B2Antibodies that bind to CCR6 and their usesIchnos Sciences SA·Filed 2015·Granted May 5, 2020·0 cites·9 claims
- 1637US2023159661A1T cell redirecting bispecific antibodies for the treatment of egfr positive cancersIchnos Sciences SA·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rami Lissilaa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →